HomeCNTX • NASDAQ
add
Context Therapeutics Inc
Previous close
$0.77
Day range
$0.75 - $0.80
Year range
$0.55 - $2.73
Market cap
70.35M USD
Avg Volume
206.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.53M | 44.61% |
Net income | -4.58M | -24.80% |
Net profit margin | — | — |
Earnings per share | -0.05 | 78.26% |
EBITDA | -5.53M | -44.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.35M | 785.62% |
Total assets | 92.97M | 741.19% |
Total liabilities | 1.98M | -23.99% |
Total equity | 90.98M | — |
Shares outstanding | 89.70M | — |
Price to book | 0.77 | — |
Return on assets | -14.47% | — |
Return on capital | -14.81% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.58M | -24.80% |
Cash from operations | -5.03M | -15.31% |
Cash from investing | -33.95K | — |
Cash from financing | -15.27K | — |
Net change in cash | -5.08M | -16.44% |
Free cash flow | -4.25M | -37.88% |
About
Founded
2015
Headquarters
Website
Employees
12
